Active surveillance of adverse events following the first dose of COVID-19 vaccination – Oxford–AstraZeneca (Covishield) vaccine
Background: COVID-19 vaccines have been the most rapidly developed vaccines in history and consequently, fears of its safety and efficacy intrigue the minds of the common man. Aims: This study was intended to determine the adverse events following COVID-19 vaccination and thereby reduce vaccine hesi...
Main Authors: | Sangeetha Merrin Varghese, Grace Mary John, Geomcy George, Linda Jacob, Mammen Paul, Arun Sachu, Abel K Samuel Johnson, George Mateethra Chandy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Saudi Journal for Health Sciences |
Subjects: | |
Online Access: | http://www.saudijhealthsci.org/article.asp?issn=2278-0521;year=2022;volume=11;issue=2;spage=104;epage=109;aulast= |
Similar Items
-
Thromboembolism and the Oxford-AstraZeneca vaccine
by: Perera, R, et al.
Published: (2021) -
COVID-19 vaccines portray the bright side of human creativity, but it means nothing until they prove their worth: A Study on Seroconversion after the first Dose of Covishield vaccine in central Kerala
by: Sangeetha Merrin Varghese, et al.
Published: (2022-01-01) -
Malaysia to use AstraZeneca vaccine
by: Povera, Adib
Published: (2021) -
Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study
by: Nishat Jahan, et al.
Published: (2021-10-01) -
Membranoproliferative Glomerulonephritis following the Oxford AstraZeneca COVID-19 Vaccine
by: Kawtar Hassani, et al.
Published: (2021-01-01)